FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

444594003: Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2868788010 Rosiglitazone 8mg + glimepiride 2mg tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    2870617018 Rosiglitazone 8mg + glimepiride 2mg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
    3471194013 Product containing rosiglitazone 8 mg and glimepiride 2 mg/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3488148014 Product containing rosiglitazone 8 mg and glimepiride 2 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
    3502282014 Rosiglitazone 8 mg and glimepiride 2 mg oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3570823011 Product containing only rosiglitazone 8 mg and glimepiride 2 mg/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3570824017 Product containing only rosiglitazone 8 mg and glimepiride 2 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
    3682846012 Glimepiride 2 mg and rosiglitazone 8 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    3682847015 Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3682848013 Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    108447501000001110 Rosiglitazone 8 mg and glimepiride 2 mg oral tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Is a Product containing glimepiride and rosiglitazone false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has active ingredient Glimepiride false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has active ingredient Rosiglitazone false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has active ingredient Glimepiride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has basis of strength substance Glimepiride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength numerator value 2 false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has active ingredient Rosiglitazone false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has basis of strength substance Rosiglitazone false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has presentation strength numerator value 8 false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has precise active ingredient Rosiglitazone false Inferred relationship Existential restriction modifier 2
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Has precise active ingredient Glimepiride false Inferred relationship Existential restriction modifier 1
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Is a Product containing glimepiride and rosiglitazone in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet Is a Product containing only glimepiride and rosiglitazone in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start